Literature DB >> 20113337

Cerebrospinal fluid hypocretin levels are normal in idiopathic REM sleep behaviour disorder.

K N Anderson1, A Vincent, I E Smith, J M Shneerson.   

Abstract

BACKGROUND: Rapid eye movement (REM) sleep behaviour disorder (RBD) is a common sleep disorder that can be associated with a number of neurodegenerative conditions as well as with narcolepsy. Current diagnostic criteria require overnight polysomnography, and there are no other biomarkers available. The control of REM sleep is complex with a putative on/off switch within the brainstem activated, amongst other things, by hypocretinergic pathways from the lateral hypothalamus.
METHODS: Cerebrospinal fluid hypocretin levels were measured in five patients with idiopathic RBD.
RESULTS: Hypocretin levels were between 254 and 450 pg/ml and therefore within the normal range of >100 pg/ml.
CONCLUSION: Hypocretin levels in patients with idiopathic RBD are normal.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20113337     DOI: 10.1111/j.1468-1331.2010.02954.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  6 in total

1.  REM sleep behavior disorder and REM sleep without atonia as an early manifestation of degenerative neurological disease.

Authors:  Stuart J McCarter; Erik K St Louis; Bradley F Boeve
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

Review 2.  Accuracy of Rating Scales and Clinical Measures for Screening of Rapid Eye Movement Sleep Behavior Disorder and for Predicting Conversion to Parkinson's Disease and Other Synucleinopathies.

Authors:  Matej Skorvanek; Eva Feketeova; Monica M Kurtis; Jan Rusz; Karel Sonka
Journal:  Front Neurol       Date:  2018-05-25       Impact factor: 4.003

3.  Cerebrospinal Fluid TNF-α and Orexin in Patients With Parkinson's Disease and Rapid Eye Movement Sleep Behavior Disorder.

Authors:  Yuan Yuan; Yimeng Zhang; Yueyang Cheng; Yue Hou; Zhaoyang Huang; Jinghong Ma; Ning Li; Shuqin Zhan
Journal:  Front Neurol       Date:  2022-02-18       Impact factor: 4.003

4.  Ventricular orexin-A (hypocretin-1) levels correlate with rapid-eye-movement sleep without atonia in Parkinson's disease.

Authors:  Agathe Bridoux; Stephane Moutereau; Ala Covali-Noroc; Laurent Margarit; Stephane Palfi; Jean-Paul Nguyen; Jean-Pascal Lefaucheur; Pierre Césaro; Marie-Pia d'Ortho; Xavier Drouot
Journal:  Nat Sci Sleep       Date:  2013-06-12

Review 5.  Neurophysiological basis of rapid eye movement sleep behavior disorder: informing future drug development.

Authors:  Poul Jennum; Julie Ae Christensen; Marielle Zoetmulder
Journal:  Nat Sci Sleep       Date:  2016-04-15

6.  Cardiac Sympathetic Activity differentiates Idiopathic and Symptomatic Rapid Eye Movement Sleep Behaviour Disorder.

Authors:  Lucie Barateau; Isabelle Jaussent; Régis Lopez; Elisa Evangelista; Sofiene Chenini; Meriem Benkiran; Denis Mariano-Goulart; Yves Dauvilliers
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.